As of 2024-12-12, the Relative Valuation of Biohaven Pharmaceutical Holding Company Ltd (BHVN) is (183.35) USD. This relative valuation is based on P/E multiples. With the latest stock price at 42.79 USD, the upside of Biohaven Pharmaceutical Holding Company Ltd based on Relative Valuation is -528.5%.
The range of the Relative Valuation is (148.74) - (163.06) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 18.3x - 34.7x | 26.5x |
| Forward P/E multiples | 18.7x - 20.5x | 19.6x |
| Fair Price | (148.74) - (163.06) | (183.35) |
| Upside | -447.6% - -481.1% | -528.5% |
| Date | P/E |
| 2024-11-29 | -5.78 |
| 2024-11-27 | -5.83 |
| 2024-11-26 | -5.94 |
| 2024-11-25 | -5.69 |
| 2024-11-22 | -5.73 |
| 2024-11-21 | -5.68 |
| 2024-11-20 | -5.89 |
| 2024-11-19 | -5.82 |
| 2024-11-18 | -5.71 |
| 2024-11-15 | -5.58 |
| 2024-11-14 | -6.12 |
| 2024-11-13 | -6.17 |
| 2024-11-12 | -6.33 |
| 2024-11-11 | -6.59 |
| 2024-11-08 | -6.72 |
| 2024-11-07 | -6.67 |
| 2024-11-06 | -6.76 |
| 2024-11-05 | -6.46 |
| 2024-11-04 | -6.29 |
| 2024-11-01 | -6.40 |
| 2024-10-31 | -6.26 |
| 2024-10-30 | -6.34 |
| 2024-10-29 | -6.41 |
| 2024-10-28 | -6.51 |
| 2024-10-25 | -6.64 |
| 2024-10-24 | -6.58 |
| 2024-10-23 | -6.63 |
| 2024-10-22 | -6.62 |
| 2024-10-21 | -6.45 |
| 2024-10-18 | -6.66 |
| 2024-10-17 | -6.49 |
| 2024-10-16 | -6.47 |
| 2024-10-15 | -6.38 |
| 2024-10-14 | -6.63 |
| 2024-10-11 | -6.75 |
| 2024-10-10 | -6.47 |
| 2024-10-09 | -6.45 |
| 2024-10-08 | -6.73 |
| 2024-10-07 | -6.63 |
| 2024-10-04 | -5.99 |
| 2024-10-03 | -5.86 |
| 2024-10-02 | -6.03 |
| 2024-10-01 | -6.11 |
| 2024-09-30 | -6.28 |
| 2024-09-27 | -6.41 |
| 2024-09-26 | -6.43 |
| 2024-09-25 | -6.19 |
| 2024-09-24 | -5.66 |
| 2024-09-23 | -5.78 |
| 2024-09-20 | -5.08 |